Role of lipid profile in the short term prognosis of acute myocardial infarction in a rural hospital in South India

Treasure, 1995, Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease, N Engl J Med, 332, 481, 10.1056/NEJM199502233320801 Mathew, 1997, Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia, Circulation, 96, 1930, 10.1161/01.CIR.96.6.1930 Vergnani, 2000, Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production, Circulation, 101, 1261, 10.1161/01.CIR.101.11.1261 Dupuis, 1999, Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes, Circulation, 99, 3227, 10.1161/01.CIR.99.25.3227 Paniagua, 1989, Study of lipids (cholesterol, triglycerides and phospholipids), plasma lipoproteins (HDL-cholesterol) and apoproteins (apo A and apo B) in patients with acute myocardial infarction, Med Clin, 93, 134 Pfohl, 2000, Upregulation of cholesterol synthesis after acute myocardial infarction – is cholesterol a positive acute phase reactant?, Atherosclerosis, 149, 215 Gore, 1984, Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction, Am J Cardiol, 54, 722, 10.1016/S0002-9149(84)80197-6 Gaziano, 1999, Clinical utility of lipid and lipoprotein levels during hospitalization for acute myocardial infarction, Vasc Med, 4, 227, 10.1177/1358836X9900400404 Haheim, 1993, The predictability of risk factors with respect to incidence and mortality of myocardial infarction and total mortality. A 12-year follow-up of the Oslo Study, Norway, Intern Med, 234, 17, 10.1111/j.1365-2796.1993.tb00699.x Wong, 1991, Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study, Ann Intern Med, 115, 687, 10.7326/0003-4819-115-9-687 Tamai, 1997, Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans, Circulation, 95, 76, 10.1161/01.CIR.95.1.76 Liao, 1995, Oxidized low density lipoprotein decreases the expression of endothelial nitric oxide synthase, J Biol Chem, 270, 319, 10.1074/jbc.270.1.319 Nickening, 1997, Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression, Am J Physiol, 272, 2701 Nofer, 1997, Low-density lipoproteins inhibit the Na/H antiport in human platelets: a novel mechanism enhancing platelet activity in hypercholesterolemia, Circulation, 95, 1370, 10.1161/01.CIR.95.6.1370 van der Wal, 1994, Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaque is characterized by an inflammatory process irrespective of the dominant plaque morphology, Circulation, 89, 36, 10.1161/01.CIR.89.1.36 Ehara, 2001, Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes, Circulation, 103, 1955, 10.1161/01.CIR.103.15.1955 Laufs, 1998, Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors, Circulation, 97, 1129, 10.1161/01.CIR.97.12.1129 Kaesemeyer, 1999, Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions, J Am Coll Cardiol, 33, 234, 10.1016/S0735-1097(98)00514-2 Aronow, 2001, Effect of lipid lowering therapy on early mortality after acute coronary syndromes: an observational study, Lancet, 357, 1063, 10.1016/S0140-6736(00)04257-4 Stenestrand, 2001, Early statin treatment following acute myocardial infarction and 1-year survival, JAMA, 285, 430, 10.1001/jama.285.4.430 Arntz, 2000, Beneficial effects of pravastatin (± Cholestyramine/Niacin) initiated immediately after a coronary event (The Randomized Lipid-Coronary Artery Disease [L-CAD] Study), Am J Cardiol, 86, 1293, 10.1016/S0002-9149(00)01230-3 Schwartz, 2001, Effects of Atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL Study: a randomized controlled trial, JAMA, 285, 1711, 10.1001/jama.285.13.1711